Medigen Biotechnology (Taiwan) Buy Hold or Sell Recommendation
| 3176 Stock | TWD 34.50 0.15 0.44% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Medigen Biotechnology is 'Strong Buy'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Medigen Biotechnology given historical horizon and risk tolerance towards Medigen Biotechnology. When Macroaxis issues a 'buy' or 'sell' recommendation for Medigen Biotechnology, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Medigen Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Medigen and provide practical buy, sell, or hold advice based on investors' constraints. Medigen Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Medigen |
Execute Medigen Biotechnology Buy or Sell Advice
The Medigen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medigen Biotechnology. Macroaxis does not own or have any residual interests in Medigen Biotechnology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medigen Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medigen Biotechnology Trading Alerts and Improvement Suggestions
| Medigen Biotechnology generated a negative expected return over the last 90 days | |
| The company reported the revenue of 3.92 B. Net Loss for the year was (52.61 M) with profit before overhead, payroll, taxes, and interest of 2.55 B. | |
| About 25.0% of the company shares are owned by insiders or employees |
Medigen Biotechnology Returns Distribution Density
The distribution of Medigen Biotechnology's historical returns is an attempt to chart the uncertainty of Medigen Biotechnology's future price movements. The chart of the probability distribution of Medigen Biotechnology daily returns describes the distribution of returns around its average expected value. We use Medigen Biotechnology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medigen Biotechnology returns is essential to provide solid investment advice for Medigen Biotechnology.
| Mean Return | -0.16 | Value At Risk | -2.27 | Potential Upside | 1.79 | Standard Deviation | 1.72 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medigen Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medigen Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medigen Biotechnology or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medigen Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medigen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | 0.61 | |
σ | Overall volatility | 1.75 | |
Ir | Information ratio | -0.16 |
Medigen Biotechnology Volatility Alert
Medigen Biotechnology exhibits very low volatility with skewness of 3.11 and kurtosis of 17.96. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Medigen Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Medigen Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Medigen Biotechnology Fundamentals Vs Peers
Comparing Medigen Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medigen Biotechnology's direct or indirect competition across all of the common fundamentals between Medigen Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medigen Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medigen Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Medigen Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medigen Biotechnology to competition |
| Fundamentals | Medigen Biotechnology | Peer Average |
| Return On Equity | -0.0022 | -0.31 |
| Return On Asset | 0.0036 | -0.14 |
| Profit Margin | (0.08) % | (1.27) % |
| Operating Margin | 0.02 % | (5.51) % |
| Current Valuation | 2.9 B | 16.62 B |
| Shares Outstanding | 139.45 M | 571.82 M |
| Shares Owned By Insiders | 25.17 % | 10.09 % |
| Shares Owned By Institutions | 2.80 % | 39.21 % |
| Price To Book | 2.01 X | 9.51 X |
| Price To Sales | 1.66 X | 11.42 X |
| Revenue | 3.92 B | 9.43 B |
| Gross Profit | 2.55 B | 27.38 B |
| EBITDA | 1.35 B | 3.9 B |
| Net Income | (52.61 M) | 570.98 M |
| Total Debt | 470.77 M | 5.32 B |
| Book Value Per Share | 18.24 X | 1.93 K |
| Cash Flow From Operations | 518.12 M | 971.22 M |
| Earnings Per Share | (0.51) X | 3.12 X |
| Number Of Employees | 18 | 18.84 K |
| Beta | 0.99 | -0.15 |
| Market Capitalization | 4.42 B | 19.03 B |
| Total Asset | 8.2 B | 29.47 B |
| Z Score | 5.4 | 8.72 |
| Net Asset | 8.2 B |
Medigen Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medigen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Medigen Biotechnology Buy or Sell Advice
When is the right time to buy or sell Medigen Biotechnology? Buying financial instruments such as Medigen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medigen Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medigen Stock Analysis
When running Medigen Biotechnology's price analysis, check to measure Medigen Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Biotechnology is operating at the current time. Most of Medigen Biotechnology's value examination focuses on studying past and present price action to predict the probability of Medigen Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Biotechnology's price. Additionally, you may evaluate how the addition of Medigen Biotechnology to your portfolios can decrease your overall portfolio volatility.